International Assets Investment Management’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,507
Closed -$896 1265
2024
Q3
$896 Buy
+13,507
New +$204K ﹤0.01% 1170
2023
Q2
Sell
-1,507
Closed -$21K 691
2023
Q1
$21K Buy
+1,507
New +$21.5K ﹤0.01% 788
2022
Q2
Sell
-10,000
Closed -$165K 505
2022
Q1
$165K Sell
10,000
-3,953
-28% -$68K 0.03% 437
2021
Q4
$268K Buy
13,953
+274
+2% +$5.51K 0.05% 374
2021
Q3
$285K Buy
13,679
+263
+2% +$5.63K 0.05% 348
2021
Q2
$288K Sell
13,416
-12,598
-48% -$254K 0.05% 341
2021
Q1
$513K Buy
26,014
+13,136
+102% +$271K 0.05% 327
2020
Q4
$254K Buy
+12,878
New +$238K 0.05% 322

Other funds holding HQL

International Assets Investment Management's HQL Position: Q4 2024 in Review

International Assets Investment Management sold out of abrdn Life Sciences Investors (HQL) in Q4 2024, closing a stake of 13,507 shares — an estimated $896 sold.

International Assets Investment Management first reported a position in HQL in Q4 2020 and held it in 8 quarters. The position peaked at $513K in Q1 2021. 72 funds tracked by Wall St. Rank hold HQL as of Q4 2024.

  • International Assets Investment Management reported no remaining abrdn Life Sciences Investors position as of Q4 2024 after selling out during the quarter.
  • International Assets Investment Management sold 13,507 abrdn Life Sciences Investors shares in Q4 2024, an estimated $896.
  • International Assets Investment Management first reported a position in abrdn Life Sciences Investors in Q4 2020 and held it in 8 quarters.
  • International Assets Investment Management's abrdn Life Sciences Investors position peaked at $513K in Q1 2021.
  • 72 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.